SHSE:600436 (China)
Â
Class A
Â¥
220.23
(-2.08%)
Apr 25
Business Description
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
NAICS : 325411
ISIN : CNE000001F21
Share Class Description:
SHSE:600436: Class ACompare
Compare
Traded in other countries / regions
600436.China IPO Date
2003-06-16Description
Zhangzhou Pientzehuang Pharmaceutical Co Ltd produces and sells Chinese medicines. The company's product categories include drugs and healthcare products, healthy foods, cosmetics, daily chemicals, and medical instruments. Some of its products include Xinshubao Tablet, Yindan Pinggan Capsule, Liuwei Dihuang Pills, and Chuangbei Qingfei Syrup.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.87 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | 0.35 | |||||
| Interest Coverage | 95.37 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 27 | |||||
| Beneish M-Score | -2.32 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 15.6 | |||||
| 3-Year EBITDA Growth Rate | 18.8 | |||||
| 3-Year EPS without NRI Growth Rate | 21.6 | |||||
| 3-Year FCF Growth Rate | 25.4 | |||||
| 3-Year Book Growth Rate | 19.4 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.74 | |||||
| 9-Day RSI | 45.96 | |||||
| 14-Day RSI | 47.16 | |||||
| 6-1 Month Momentum % | -3.9 | |||||
| 12-1 Month Momentum % | -10.85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.27 | |||||
| Quick Ratio | 4.02 | |||||
| Cash Ratio | 0.77 | |||||
| Days Inventory | 197.12 | |||||
| Days Sales Outstanding | 26.92 | |||||
| Days Payable | 35.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.56 | |||||
| Dividend Payout Ratio | 0.25 | |||||
| 3-Year Dividend Growth Rate | 15.1 | |||||
| Forward Dividend Yield % | 0.56 | |||||
| 5-Year Yield-on-Cost % | 1.64 | |||||
| Shareholder Yield % | 0.47 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 46.53 | |||||
| Operating Margin % | 33.05 | |||||
| Net Margin % | 28.32 | |||||
| FCF Margin % | 18.56 | |||||
| ROE % | 23.11 | |||||
| ROA % | 18.21 | |||||
| ROIC % | 23.7 | |||||
| ROC (Joel Greenblatt) % | 33.82 | |||||
| ROCE % | 26.32 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 44.22 | |||||
| PE Ratio without NRI | 44 | |||||
| Shiller PE Ratio | 85.69 | |||||
| Price-to-Owner-Earnings | 46.82 | |||||
| PEG Ratio | 2.1 | |||||
| PS Ratio | 12.53 | |||||
| PB Ratio | 9.27 | |||||
| Price-to-Tangible-Book | 9.46 | |||||
| Price-to-Free-Cash-Flow | 67.46 | |||||
| Price-to-Operating-Cash-Flow | 63.14 | |||||
| EV-to-EBIT | 36.98 | |||||
| EV-to-EBITDA | 36.98 | |||||
| EV-to-Revenue | 12.68 | |||||
| EV-to-FCF | 69.76 | |||||
| Price-to-Projected-FCF | 3.69 | |||||
| Price-to-DCF (Earnings Based) | 1.41 | |||||
| Price-to-DCF (FCF Based) | 2.16 | |||||
| Price-to-Median-PS-Value | 0.88 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.07 | |||||
| Price-to-Graham-Number | 4.3 | |||||
| Price-to-Net-Current-Asset-Value | 10.75 | |||||
| Earnings Yield (Greenblatt) % | 2.7 | |||||
| FCF Yield % | 1.48 | |||||
| Forward Rate of Return (Yacktman) % | 21.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 10,599.672 | ||
| EPS (TTM) (Â¥) | 4.98 | ||
| Beta | 1.6 | ||
| Volatility % | 28.64 | ||
| 14-Day RSI | 47.16 | ||
| 14-Day ATR (Â¥) | 4.954838 | ||
| 20-Day SMA (Â¥) | 226.8475 | ||
| 12-1 Month Momentum % | -10.85 | ||
| 52-Week Range (Â¥) | 180.69 - 321 | ||
| Shares Outstanding (Mil) | 603.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Frequently Asked Questions
What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd(SHSE:600436)'s stock price today?
The current price of SHSE:600436 is ¥220.23. The 52 week high of SHSE:600436 is ¥321.00 and 52 week low is ¥180.69.
When is next earnings date of Zhangzhou Pientzehuang Pharmaceutical Co Ltd(SHSE:600436)?
The next earnings date of Zhangzhou Pientzehuang Pharmaceutical Co Ltd(SHSE:600436) is .
Does Zhangzhou Pientzehuang Pharmaceutical Co Ltd(SHSE:600436) pay dividends? If so, how much?
The Dividend Yield %  of Zhangzhou Pientzehuang Pharmaceutical Co Ltd(SHSE:600436) is 0.56% (As of Today), Highest Dividend Payout Ratio of Zhangzhou Pientzehuang Pharmaceutical Co Ltd(SHSE:600436) was 0.4. The lowest was 0.21. And the median was 0.28. The  Forward Dividend Yield % of Zhangzhou Pientzehuang Pharmaceutical Co Ltd(SHSE:600436) is 0.56%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers